CMTP Issues Draft Framework for Covering NGS Testing

An influential not-for-profit group has issued a draft framework for how next-generation sequencing tests for oncology care should be reimbursed by payers. The report from The Center for Medical Technology Policy (CMTP) comes at a time when anxiety regarding the rates of reimbursement for molecular-based tests has been running high. Many of the regional fiscal…